Content by Parse Biosciences

Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced an alliance with bit.bio to create a comprehensive map of transcription factor-driven cell identity

Partnership unites AI and single cell technology to map immune dysfunction and improve drug discovery and development outcomes

Single-cell sequencing can yield a treasure trove of information on immune cell population characteristics and behavior.

Researchers aim to identify cellular circuit mechanisms and generate a dataset to fuel AI-driven foundational research of lung biology

Using artificial intelligence and single-cell transcriptomics, scientists mapped drug response patterns across 100 million cancer cells.

Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies

The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.